Caricamento...
Secondary Adrenal Insufficiency Due to the Co-Administration of Ritonavir and Inhaled Fluticasone Propionate: Case report
Ritonavir is a powerful inhibitor of the cytochrome P450 3A4 (CYP3A4) isoenzyme. It is used as a pharmaceutical enhancer in the management of HIV-positive patients. However, when co-administered with other drugs that are metabolised via the CYP3A4 pathway, ritonavir can potentially cause serious dru...
Salvato in:
| Pubblicato in: | Sultan Qaboos Univ Med J |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Sultan Qaboos University Medical Journal, College of Medicine & Health Sciences
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5642366/ https://ncbi.nlm.nih.gov/pubmed/29062559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18295/squmj.2017.17.03.014 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|